David Klumpar, MD
Dermatology · Pinehurst, NCNPI 1730283276
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 286 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Novartis at 29.9% of the total. Reporting peaked in 2019 at $2,485 and has fallen 95.7% since, to $107 in 2024.
Across 286 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- AbbVie$596
- Sun Pharmaceutical Industries Inc.$397
- Johnson & Johnson$277
- Almirall LLC$270
- Pfizer$252
- plus $2K from 22 others
What the payments were for
- Travel & lodging$481%
- Food & beverage$5,30197%
- Education$1022%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 92 | $1,631 |
| AbbVie | 30 | $596 |
| Sun Pharmaceutical Industries Inc. | 14 | $397 |
| Johnson & Johnson | 12 | $277 |
| Almirall LLC | 7 | $270 |
| Pfizer | 26 | $252 |
| LEO Pharma Inc. | 9 | $203 |
| E.r. Squibb & Sons, L.L.C. | 5 | $199 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $195 |
| VYNE Pharmaceuticals Inc. | 8 | $162 |
| Regeneron Healthcare Solutions, Inc. | 6 | $131 |
| Sanofi | 2 | $127 |
| Incyte Corporation | 11 | $125 |
| Mayne Pharma Commercial LLC | 6 | $120 |
| EPI Health, LLC | 6 | $119 |
| Bristol Myers Squibb | 1 | $97 |
| Janssen Scientific Affairs, LLC | 1 | $96 |
| Lilly USA, LLC | 5 | $87 |
| UCB, Inc. | 5 | $80 |
| Prugen, Inc. Pharmaceuticals | 14 | $73 |
| Galderma Laboratories, L.p. | 4 | $59 |
| Arcutis Biotherapeutics, Inc. | 2 | $42 |
| Strata Skin Sciences, Inc. | 4 | $33 |
| Biofrontera Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Merck | 1 | $13 |
| Glenmark Therapeutics Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,452 in reported general payments places this provider in the 70th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Pinehurst
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
- Patrick McElgunnCharlotte$565K
- George MagelHickory$554K
- Muneeb ShahClinton$451K
- John SoderbergCary$398K
- Rosalyn GeorgeWilmington$346K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.